rs370630496
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The ENST00000344100.7(CACNA1C):c.4002C>G(p.Asp1334Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000131 in 152,150 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D1334N) has been classified as Likely benign.
Frequency
Consequence
ENST00000344100.7 missense
Scores
Clinical Significance
Conservation
Publications
- Timothy syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
- neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizuresInheritance: AD Classification: STRONG Submitted by: Ambry Genetics
- long QT syndromeInheritance: AD Classification: MODERATE Submitted by: ClinGen
- long QT syndrome 8Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- Brugada syndromeInheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
- Brugada syndrome 3Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- intellectual disabilityInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- short QT syndromeInheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1C | ENST00000344100.7 | c.4002C>G | p.Asp1334Glu | missense_variant | Exon 32 of 47 | 1 | ENSP00000341092.3 | |||
CACNA1C | ENST00000399603.6 | c.3946-10C>G | intron_variant | Intron 31 of 46 | 5 | NM_001167623.2 | ENSP00000382512.1 | |||
CACNA1C | ENST00000399655.6 | c.3946-10C>G | intron_variant | Intron 31 of 46 | 1 | NM_000719.7 | ENSP00000382563.1 | |||
CACNA1C | ENST00000682544.1 | c.4180-10C>G | intron_variant | Intron 33 of 49 | ENSP00000507184.1 | |||||
CACNA1C | ENST00000406454.8 | c.3946-10C>G | intron_variant | Intron 31 of 47 | 5 | ENSP00000385896.3 | ||||
CACNA1C | ENST00000399634.6 | c.3913-10C>G | intron_variant | Intron 30 of 46 | 5 | ENSP00000382542.2 | ||||
CACNA1C | ENST00000683824.1 | c.4111-10C>G | intron_variant | Intron 32 of 47 | ENSP00000507867.1 | |||||
CACNA1C | ENST00000347598.9 | c.4090-10C>G | intron_variant | Intron 33 of 48 | 1 | ENSP00000266376.6 | ||||
CACNA1C | ENST00000327702.12 | c.3946-10C>G | intron_variant | Intron 31 of 47 | 1 | ENSP00000329877.7 | ||||
CACNA1C | ENST00000399617.6 | c.3946-10C>G | intron_variant | Intron 31 of 47 | 5 | ENSP00000382526.1 | ||||
CACNA1C | ENST00000682462.1 | c.4036-10C>G | intron_variant | Intron 31 of 46 | ENSP00000507105.1 | |||||
CACNA1C | ENST00000683781.1 | c.4036-10C>G | intron_variant | Intron 31 of 46 | ENSP00000507434.1 | |||||
CACNA1C | ENST00000683840.1 | c.4036-10C>G | intron_variant | Intron 31 of 46 | ENSP00000507612.1 | |||||
CACNA1C | ENST00000683956.1 | c.4036-10C>G | intron_variant | Intron 31 of 46 | ENSP00000506882.1 | |||||
CACNA1C | ENST00000399638.5 | c.4030-10C>G | intron_variant | Intron 32 of 47 | 1 | ENSP00000382547.1 | ||||
CACNA1C | ENST00000335762.10 | c.4021-10C>G | intron_variant | Intron 32 of 47 | 5 | ENSP00000336982.5 | ||||
CACNA1C | ENST00000399606.5 | c.4006-10C>G | intron_variant | Intron 32 of 47 | 1 | ENSP00000382515.1 | ||||
CACNA1C | ENST00000399621.5 | c.3946-10C>G | intron_variant | Intron 31 of 46 | 1 | ENSP00000382530.1 | ||||
CACNA1C | ENST00000399637.5 | c.3946-10C>G | intron_variant | Intron 31 of 46 | 1 | ENSP00000382546.1 | ||||
CACNA1C | ENST00000402845.7 | c.3946-10C>G | intron_variant | Intron 31 of 46 | 1 | ENSP00000385724.3 | ||||
CACNA1C | ENST00000399629.5 | c.3997-10C>G | intron_variant | Intron 31 of 46 | 1 | ENSP00000382537.1 | ||||
CACNA1C | ENST00000682336.1 | c.3988-10C>G | intron_variant | Intron 31 of 46 | ENSP00000507898.1 | |||||
CACNA1C | ENST00000399591.5 | c.3913-10C>G | intron_variant | Intron 30 of 45 | 1 | ENSP00000382500.1 | ||||
CACNA1C | ENST00000399595.5 | c.3913-10C>G | intron_variant | Intron 30 of 45 | 1 | ENSP00000382504.1 | ||||
CACNA1C | ENST00000399649.5 | c.3907-10C>G | intron_variant | Intron 30 of 45 | 1 | ENSP00000382557.1 | ||||
CACNA1C | ENST00000399597.5 | c.3946-10C>G | intron_variant | Intron 31 of 46 | 1 | ENSP00000382506.1 | ||||
CACNA1C | ENST00000399601.5 | c.3946-10C>G | intron_variant | Intron 31 of 46 | 1 | ENSP00000382510.1 | ||||
CACNA1C | ENST00000399641.6 | c.3946-10C>G | intron_variant | Intron 31 of 46 | 1 | ENSP00000382549.1 | ||||
CACNA1C | ENST00000399644.5 | c.3946-10C>G | intron_variant | Intron 31 of 46 | 1 | ENSP00000382552.1 | ||||
CACNA1C | ENST00000682835.1 | c.3946-10C>G | intron_variant | Intron 31 of 46 | ENSP00000507282.1 | |||||
CACNA1C | ENST00000683482.1 | c.3937-10C>G | intron_variant | Intron 31 of 46 | ENSP00000507169.1 | |||||
CACNA1C | ENST00000682686.1 | c.3913-10C>G | intron_variant | Intron 30 of 45 | ENSP00000507309.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152150Hom.: 0 Cov.: 32 show subpopulations
GnomAD4 exome Cov.: 33
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152150Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74330 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Long QT syndrome Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. ClinVar contains an entry for this variant (Variation ID: 411722). This variant has not been reported in the literature in individuals affected with CACNA1C-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change falls in intron 31 of the CACNA1C gene. It does not directly change the encoded amino acid sequence of the CACNA1C protein. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at